February 23, 2022 01:14 PM ESTUpdated February 25, 12:39 PM
Pharma
Marketing

Phar­ma sus­tain­abil­i­ty: Am­gen de­buts $750M ‘green bond,’ Mer­ck ini­ti­ates ESG goal re­view

Beth Snyder Bulik

Senior Editor

A pair of en­vi­ron­ment, so­cial and gov­er­nance (ESG) news re­ports this week point out the em­pha­sis phar­ma is putting on sus­tain­abil­i­ty ef­forts thanks to in­creas­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times